Security key
31189P102
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 80,446,666
- Total 13F value
- $101,355,707
- Share change
- +1,160,185
- Put/Call ratio
- 38%
- SEC-reported price per share
- $1.26
- Number of holders
- 138
- Value change
- +$1,878,808
- Number of buys
- 63
- Number of sells
- 53
- Shares outstanding
- 115,488,632
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
138
Top holders
10
FATE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
FATE THERAPEUTICS INC SEC filings
FATE THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31189P102
Recent filing periods:
Ownership snapshot
Top reported holders of FATE - FATE THERAPEUTICS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GOLDMAN SACHS GROUP INC
Disclosed value leader
Redmile Group, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13F
13D/G
Lead comparable stake: 2%
13D/G row: GOLDMAN SACHS GROUP INC
Showing 1-6 of 15 holder rows.
Quick read
GOLDMAN SACHS GROUP INC leads the comparable SEC ownership view at 2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GOLDMAN SACHS GROUP INC's linked filing trail.
Comparable ownership
Top 5
GOLDMAN SACHS GROUP INC
2%
Schonfeld Strategic Advisors LLC
0.82%
Redmile Group, LLC
11%
BlackRock, Inc.
9.4%
VANGUARD GROUP INC
7.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC |
13F
13D/G
Company · THE GOLDMAN SACHS GROUP, INC.
|
2%
from 13D/G
|
$2,813,077
2,511,676 shares
|
— | 30 Jun 2025 |
| Schonfeld Strategic Advisors LLC |
13D/G
13F
Company
|
0.82%
|
$1,050,024
937,521 shares
|
-$7,679,831 | 30 Jun 2025 |
| Redmile Group, LLC |
13F
Company
|
11%
|
$14,417,700
12,872,946 shares
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13F
Company
|
9.4%
|
$12,107,739
10,810,481 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
7.6%
|
$9,818,776
8,766,764 shares
|
— | 30 Jun 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
3.9%
|
$5,089,131
4,543,867 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
138
Shares
80,446,666
Rows available
138
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
136
Q3 2025 holders
138
Holder diff
2
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend